DOCSLIB.ORG

Rabid : a Cultural History of the World's Most Diabolical Virus

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rabid : a Cultural History of the World's Most Diabolical Virus Rabid : a cultural history of the world's most diabolical virus Creator: Wasik, Bill, author. Contributor: Murphy, Monica, 1974- author. Subject: Rabies -- Epidemiology -- History; Rabies -- Treatment -- History; Tollwut MESH subjects: Rabies -- History; Rabies Vaccines -- History Description: Charts the history, science, and cultural mythology of rabies, documenting how before its vaccine the disease caused fatal brain infections and sparked the creations of monsters, including werewolves, vampires and zombies. Contents: Looking the devil in the eye -- In the beginning -- The middle rages -- A virus with teeth? -- Canicide -- King Louis -- The zoonotic century -- The survivors -- Island of the mad dogs -- The devil, leashed. Publisher: New York : Viking Creation Date: 2012 Format: x, 275 pages : illustrations ; 22 cm. Source: Alma Identifier: LC: 2011043903; OCLC: (OCoLC)ocn759911217; OCLC: (OCoLC)759911217; ISBN: 9780670023738; ISBN: 0670023736 Availability and location: Pacific Lutheran University: unavailable: Mortvedt Library Main Collection - 2nd Floor RC148.W37 2012 The Black Death, 1346-1353 : the complete history Creator: Benedictow, Ole Jørgen. Subject: Black Death -- History; Plague -- History; Diseases and history; Medicine, Medieval MESH subjects: Disease Outbreaks -- history; Plague -- history; History, Medieval Contents: What was the Black Death -- Spread of the Black Death -- Patterns and dynamics of the Black Death -- Mortality in the Black Death -- The Black Death: its impact on history. Publisher: Woodbridge, Suffolk, UK ; Rochester, N.Y., USA : Boydell Press Creation Date: 2004 Format: xvi, 433 p. : ill. ; 34 cm. Source: Alma Identifier: LC: 2003024313; ISBN: 0851159435 (Hardback : alk. paper); ISBN: 1843832143 (pbk.); OCLC: (OCoLC)ocm53375968; OCLC: (OCoLC)53375968 Availability and location: Pacific Lutheran University: unavailable: Mortvedt Library Main Collection - 2nd Floor RC172.B46 2004 Beating back the devil : on the front lines with the disease detectives of the Epidemic Intelligence Service Creator: McKenna, Maryn. Subject: Centers for Disease Control (U.S.) Epidemic Intelligence Service; Epidemiology; Epidemiologists -- United States MESH subjects: Centers for Disease Control (U.S.) Epidemic Intelligence Service; Epidemiology -- history; History, 20th Century Genre: Popular works. Contents: Prologue : July 2002, Anniston, Alabama -- Training : July 2002, Atlanta -- Polio : 1955, Atlanta -- West Nile virus : August-October 2002, Atlanta -- Smallpox : 1972, Bangladesh -- Listeriosis : August-November 2002, Philadelphia -- AIDS : 1981, Los Angeles -- Uniformity : November-December 2002, Atlanta -- War : 1994, Zaire -- Malaria : March 2003, Malawi -- Tuberculosis : 1999-2000, Baltimore and New York -- Drug-resistant staphylococcus : March-June 2003, Los Angeles -- Terrorism : 2001, New York City and Washington, D.C. -- SARS : March-July 2003, Hanoi and Bangkok -- Epilogue : July-September 2003. Publisher: New York : Free Press Creation Date: c2004 Format: x, 303 p. ; 24 cm. Source: Alma Identifier: LC: 2004053214; ISBN: 0743251326; OCLC: (OCoLC)ocm55729837; OCLC: (OCoLC)55729837 Availability and location: Pacific Lutheran University: unavailable: Mortvedt Library Main Collection - 2nd Floor RA653.M38 2004 Inside the outbreaks : the elite medical detectives of the epidemic intelligence service Creator: Pendergrast, Mark. Subject: Centers for Disease Control (U.S.) Epidemic Intelligence Service; Epidemiology; Epidemiologists -- United States MESH subjects: Centers for Disease Control (U.S.) Epidemic Intelligence Service; Communicable Disease Control -- history -- United States; Epidemiology -- history -- United States; History, 20th Century -- United States; United States Government Agencies -- United States Genre: Popular works. Description: A history of the elite medical corps at the forefront of the world's most dangerous epidemics cites their victories over such diseases as polio, cholera, and smallpox. Contents: Cold war, hot pathogens -- Throwing them overboard -- Killer vaccine, goat-hair anthrax, rabid bats, and staph attacks -- Pandemic flu, purple enteritis on mars, polio problems -- New discoveries and mysteries in the early sixties -- The diaspora -- Fighting pox, pandemics, and special pathogens -- Eradication escalation -- Not just infections any more -- Surveillance and containment -- Target zero -- The year of living dangerously -- Superwomen (and men) of the late seventies -- Budget wars and new plagues -- Entering the computer age -- Unexpected connections -- Emerging infections -- Rough sledding -- Approaching a new millennium -- Full circle -- Into the twenty-first century -- L'expérience fait la difference. Publisher: Boston : Houghton Mifflin Harcourt Creation Date: 2010 Format: xiv, 418 p., [8] p. of plates : ill. ; 24 cm. Source: Alma Identifier: LC: 2009029871; ISBN: 9780151011209; OCLC: (OCoLC)ocn427608850; OCLC: (OCoLC)427608850 Availability and location: Pacific Lutheran University: unavailable: Mortvedt Library Main Collection - 2nd Floor RA653.P46 2010 Cherokee medicine, colonial germs : an indigenous nation's fight against smallpox, 1518-1824 Creator: Kelton, Paul, author. Subject: Cherokee Indians -- Diseases -- History; Smallpox -- Southern States -- History; Cherokee Indians -- Medicine -- History; Cherokee Indians -- Colonization -- Health aspects -- History; Smallpox vaccine -- Southern States -- History MESH subjects: Indians, North American -- Southeastern United States -- History; Smallpox -- Southeastern United States -- History; Colonialism -- Southeastern United States -- History; History, 16th Century -- Southeastern United States; History, Modern 1601- -- Southeastern United States; Smallpox Vaccine -- Southeastern United States -- History Description: "How smallpox, or Variola, caused widespread devastation during the European colonization of the Americas is a well-known story. But as historian Paul Kelton informs us, that's precisely what it is: a convenient story. In Cherokee Medicine, Colonial Germs Kelton challenges the "virgin soil thesis," or the widely held belief that Natives' lack of immunities and their inept healers were responsible for their downfall. Eschewing the metaphors and hyperbole routinely associated with the impact of smallpox, he firmly shifts the focus to the root cause of indigenous suffering and depopulation - colonialism writ large; not disease." -- dust jacket. Contents: Arrival -- Response -- War -- Revolution -- Vaccine. Series: New directions in Native American studies ; volume 11; New directions in Native American studies ; v. 11. Publisher: Norman : University of Oklahoma Press Creation Date: 2015 Format: xiv, 281 pages : illustrations, maps ; 24 cm. Source: Alma Identifier: LC: 2014030514; OCLC: (OCoLC)ocn890436715; OCLC: (OCoLC)890436715; ISBN: 9780806146881; ISBN: 0806146885 Availability and location: Pacific Lutheran University: unavailable: Mortvedt Library Main Collection - 2nd Floor RA644.S6K45 2015 The SARS epidemic : challenges to China's crisis management Contributor: Wong, John, 1939-; Zheng, Yongnian. Subject: SARS (Disease) -- China MESH subjects: Severe Acute Respiratory Syndrome -- epidemiology -- China; Disease Outbreaks -- prevention & control -- China; Severe Acute Respiratory Syndrome -- prevention & control -- China Publisher: Singapore ; River Edge, NJ : World Scientific Creation Date: c2004 Format: vii, 226 p. : ill. ; 24 cm. Source: Alma Identifier: LC: 2004348825; ISBN: 9812389482; OCLC: (OCoLC)ocm56794355; OCLC: (OCoLC)56794355 Availability and location: Pacific Lutheran University: unavailable: Mortvedt Library Main Collection - 2nd Floor RA644.S17S27x 2004 Flu : the story of the great influenza pandemic of 1918 and the search for the virus that caused it Creator: Kolata, Gina Bari, 1948- Subject: Influenza -- History -- 20th century Description: The fascinating, true story of the world's deadliest disease. In 1918, the Great Flu Epidemic felled the young and healthy virtually overnight. An estimated forty million people died as the epidemic raged. Children were left orphaned and families were devastated. As many American soldiers were killed by the 1918 flu as were killed in battle during World War I. And no area of the globe was safe. Eskimos living in remote outposts in the frozen tundra were sickened and killed by the flu in such numbers that entire villages were wiped out. Scientists have recently rediscovered shards of the flu virus frozen in Alaska and preserved in scraps of tissue in a government warehouse. The author unravels the mystery of this lethal virus with the high drama of a great adventure story. Delving into the history of the flu and previous epidemics, detailing the science and the latest understanding of this mortal disease, she addresses the prospects for a great epidemic recurring, and, most important, what can be done to prevent it. Contents: Prologue -- 1. The plague year -- 2. A history of disease and death -- 3. From sailors to swine -- 4. A Swedish adventurer -- 5. Swine flu -- 6. A litigation nightmare -- 7. John Dalton's eyeballs -- 8. An incident in Hong Kong -- 9. From Alaska to Norway -- 10. Mysteries and hypotheses -- Epilogue -- Acknowledgments -- Notes -- Index. Other title: Story of the great influenza pandemic of 1918 and the search for the virus that caused it; Flu (with a new epilogue about avian flu) : the story of the great influenza pandemic of 1918 and the search for the virus that caused it Publisher: New York : Simon & Schuster Creation Date: c2005 Edition: 1st Touchstone ed.
Load more

Recommended publications
  • 14 Novembre 2018 La Recherche Sur La Technologie "Gene Drive" Peut
    14 Novembre 2018 La recherche sur la technologie "gene drive" peut bénéficier la conservation et la santé publique La communauté internationale est confrontée à des défis existentiels qui compromettent notre future, de la perte catastrophique de la biodiversité à de graves menaces pour la santé publique. Les cas de paludisme sont à nouveau à la hausse après des décennies de progrès, et les écosystèmes fragiles connaissent une intensification croissante des extinctions. Ces défis nécessitent des outils nouveaux et complémentaires si nous voulons atteindre les Objectifs de Développement Durable et les Objectifs d'Aichi.i. Alors que la Convention sur la Diversité Biologique (CDB) se réunit pour la 14ème Conférence des Parties (COP14) en Égypte en novembre, les autorités des pays du monde entier auront l'occasion de réaffirmer l'importance de permettre la recherche pour soutenir l'innovation responsable et la prise de décision basée sur des évidences. Fermer la porte à la recherche en créant des barrières arbitraires, une forte incertitude, et des retards indéterminés limitera considérablement notre capacité à fournir des réponses aux questions que les responsables politiques, les régulateurs, et le public sont en train de poser. Le moratoire proposé au sein du CDB sur les lâchers expérimentaux empêcherait l’évaluation complète des utilisations potentielles du « gene drive ». La faisabilité et les modalités de tout lâcher expérimental devrait plutôt être évaluées au cas par cas. Une grande partie des progrès que nous avons réalisés au cours du siècle dernier en matière d’amélioration des moyens de subsistance et du bien-être des communautés du monde entier est le résultat de l’accroissement des connaissances acquises grâce à la recherche scientifique.
    [Show full text]
  • MRC Centre for Outbreak Analysis and Modelling
    Centre for Outbreak Analysis and Modelling MRC Centre for ANNUAL REPORT Outbreak Analysis and Modelling www.imperial.ac.uk/medicine/outbreaks 2012 The Centre specialises in quantitative epidemiology encompassing mathematical modelling, statistical analysis and evolutionary epidemiology, to aid the control and Director’s message treatment of infectious diseases. April 2013 sees the Centre renewed for a second 5-year Consortium (led by Tim Hallett) and the Vaccine Modelling term, after we received an unprecedented 10 out of 10 Initiative – are up for renewal. However, grants are only score from the MRC subcommittee, which assessed the one aspect of the relationship. As important are the close performance of the Centre over its first term. Just as the working relationships between staff in the Centre and the work of the Centre over that time has been very much a Foundation, which sees our research increasingly used to team effort, so was the success of the renewal. inform Foundation strategy and delivery. The last few months have seen us start to drive through Despite its title, the Centre’s mission rapidly evolved to our strategy for the next 5 years. A crucial aspect of this encompass delivering innovative epidemiological analysis is to boost capacity in key research areas. It is therefore not only of novel infectious disease outbreaks, but also of my pleasure to welcome new academic staff into the endemic diseases of major global health significance. Our Centre. Xavier Didelot joined us last year as a lecturer in work on polio, malaria and HIV reflects this. However, the pathogen genetics, and our expertise in evolutionary and last few months have highlighted the ongoing relevance of genetic research will be further boosted this year by the our original mission to enhance preparedness and response recruitment of at least one additional member of academic to emerging disease threats.
    [Show full text]
  • Evaluating the Roadmap out of Lockdown: Step 3
    2021-05-05 Imperial College London Evaluating the Roadmap out of Lockdown: Step 3 Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Edward S Knock, Pablo N Perez-Guzman, Tara Mangal, Alexandra B Hogan, Erik M Volz, Azra Ghani, Neil M Ferguson, Marc Baguelin, Anne Cori MRC Centre for Global Infectious Disease Analysis, Imperial College London 1. Summary In this report, we summarise the findings of our evaluation of the successive easing of non- pharmaceutical interventions (NPIs) as set out in the UK Government’s Roadmap out of Lockdown. Full methods, data used, and parameter values assumed for forward projections are given in the technical appendix. Key parameters relevant to interpretation of findings are provided in the text. Results and assumptions refer to England unless otherwise specified. 1. We estimate the current level of transmission, Reff, is approximately 1 in England. This estimate may not fully capture the impact of schools opening after Easter given the 3-week delay before changes in contact rates are reflected in surveillance data streams. 2. Based on PHE data available to 28 April 2021, 64% of the adult population in England have received at least one vaccine dose and 26% have received two doses. Under our central assumptions on vaccine effectiveness, this translates to 40% of adults (or 31% of the whole population) protected against symptomatic disease and 49% of adults (or 38% of the whole population) protected against severe disease (hospitalisation) via vaccination. Note this also includes individuals who are also protected due to recovery from past infection. 3. We estimate that an additional 15% of the population who are not protected through vaccination are currently protected due to recovery from past infection.
    [Show full text]
  • Weekly COVID-19 Pandemic Briefing – Mathematical Modelling and Response Decisions
    Transcript Webinar: Weekly COVID-19 Pandemic Briefing – Mathematical Modelling and Response Decisions Professor David Heymann CBE Distinguished Fellow, Global Health Programme, Chatham House, Executive Director, Communicable Diseases Cluster, World Health Organization (1998-2003) Professor Azra Ghani Chair of Infectious Disease Epidemiology, Imperial College London Chair: Emma Ross Senior Consulting Fellow, Global Health Programme, Chatham House Event date: 01 July 2020 The views expressed in this document are the sole responsibility of the speaker(s) and participants, and do not necessarily reflect the view of Chatham House, its staff, associates or Council. Chatham House is independent and owes no allegiance to any government or to any political body. It does not take institutional positions on policy issues. This document is issued on the understanding that if any extract is used, the author(s)/speaker(s) and Chatham House should be credited, preferably with the date of the publication or details of the event. Where this document refers to or reports statements made by speakers at an event, every effort has been made to provide a fair representation of their views and opinions. The published text of speeches and presentations may differ from delivery. © The Royal Institute of International Affairs, 2020. 10 St James’s Square, London SW1Y 4LE T +44 (0)20 7957 5700 F +44 (0)20 7957 5710 www.chathamhouse.org Patron: Her Majesty The Queen Chair: Jim O’Neill Director: Dr Robin Niblett Charity Registration Number: 208223 2 Webinar: Weekly COVID-19 Pandemic Briefing – Mathematical Modelling and Response Decisions Emma Ross Good morning and thank you for joining us for this week’s Chatham House COVID-19 briefing with Distinguished Fellow David Heymann.
    [Show full text]
  • Covid-19: Moderna Applies for US and EU Approval As Vaccine
    NEWS BMJ: first published as 10.1136/bmj.m4709 on 2 December 2020. Downloaded from The BMJ Cite this as: BMJ 2020;371:m4709 Covid-19: Moderna applies for US and EU approval as vaccine trial http://dx.doi.org/10.1136/bmj.m4709 reports 94.1% efficacy Published: 02 December 2020 Elisabeth Mahase The drug company Moderna has applied for covid-19 disease, the statistical uncertainty in this is emergency use authorisation from the US Food and such that the data are compatible with a true efficacy Drug Administration and conditional approval from of about 87%. the European Medicines Agency for its covid-19 “This is of course, still a very good efficacy. Similarly, vaccine. the 100% efficacy against more severe disease is The move comes after new results were released from compatible with an efficacy of 90%—again, this is its phase III trial, showing vaccine efficacy of 94.1% very good and is some evidence that severe as well based on 196 covid-19 cases, of which 185 were in the as mild disease is prevented.” placebo group. Azra Ghani, infectious disease epidemiology chair at The company expects an FDA meeting to take place Imperial College London, said, “The results have been on 17 December to review the safety and efficacy data. tested across a diverse population and are reported It also plans to submit the phase III data to a peer as being consistent in different subgroups, although reviewed publication. these numbers are not given and we should wait for further information in the scientific article that is By the end of 2020 an estimated 20 million doses of being prepared.
    [Show full text]
  • New Data on Oxford Astrazeneca Vaccine Backs 12 Week Dosing
    NEWS BMJ: first published as 10.1136/bmj.n326 on 3 February 2021. Downloaded from London, UK Cite this as: BMJ 2021;372:n326 Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week http://dx.doi.org/10.1136/bmj.n326 dosing interval Published: 03 February 2021 Jacqui Wise The UK’s approach of leaving an interval of three reassures us that people are protected from 22 days months between doses of the Oxford AstraZeneca after a single dose of the vaccine.” covid-19 vaccine has been supported by new data, Commenting on the study, Paul Hunter, professor in with the Oxford University researchers also saying medicine at the University of East Anglia, said, the vaccine “may have a substantial impact on “Taking all this evidence together, the 12 week gap transmission.” between first and second dose is clearly the better The paper, a preprint currently under review at the strategy as more people can be protected more Lancet, is an analysis of additional data from trials quickly and the ultimate protective effect is greater. involving 17 177 participants in the UK, Brazil, and Given the poor efficacy at preventing asymptomatic South Africa.1 It includes the results of a further infections, the vaccine will not stop transmission of month of data collection with 332 cases of covid but will still go a long way to reduce the R value symptomatic covid-19—an additional 201 cases than and transmission because there will be far fewer were previously reported.2 symptomatic infections and people who are symptomatic are rather more infectious than those A single standard dose of vaccine provided 76% who are asymptomatic.” protection overall against symptomatic covid-19 in the first 90 days after vaccination with protection not Azra Ghani, chair in infectious disease epidemiology falling in this time frame.
    [Show full text]
  • Report 20: Using Mobility to Estimate the Transmission Intensity of COVID-19 in Italy: a Subnational Analysis with Future Scenarios
    4th May 2020 Imperial College COVID-19 Response Team Report 20: Using mobility to estimate the transmission intensity of COVID-19 in Italy: A subnational analysis with future scenarios Michaela A. C. Vollmer∗, Swapnil Mishra∗, H Juliette T Unwin∗, Axel Gandy∗, Thomas A. Mellan, Valerie Bradley, Harrison Zhu, Helen Coupland, Iwona Hawryluk, Michael Hutchinson, Oliver Ratmann, Melodie Monod, Patrick Walker, Charlie Whittaker, Lorenzo Cattarino, Constance Ciavarella, Lucia Cilloni, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Nicholas Brazeau, Giovanni Charles, Laura V Cooper, Zulma Cucunuba, Gina Cuomo-Dannenburg, Amy Dighe, Bimandra Djaafara, Jeff Eaton, Sabine L van Elsland, Richard FitzJohn, Keith Fraser, Katy Gaythorpe, Will Green, Sarah Hayes, Natsuko Imai, Ben Jeffrey, Edward Knock, Daniel Laydon, John Lees, Tara Mangal, Andria Mousa, Gemma Nedjati-Gilani, Pierre Nouvellet, Daniela Olivera, Kris V Parag, Michael Pickles, Hayley A Thompson, Robert Verity, Car- oline Walters, Haowei Wang, Yuanrong Wang, Oliver J Watson, Lilith Whittles, Xiaoyue Xi, Azra Ghani, Steven M Riley, Lucy Okell, Christl A. Donnelly, Neil M Ferguson1, Ilaria Dorigatti3, Seth Flaxman∗ and Samir Bhatt2∗ Department of Infectious Disease Epidemiology, Imperial College London Department of Mathematics, Imperial College London WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analytics Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London Department of Statistics, University of Oxford ∗Contributed equally. Correspondence: [email protected] [email protected] 3i.dori- [email protected] Summary Italy was the first European country to experience sustained local transmission of COVID-19. Asof1st May 2020, the Italian health authorities reported 28;238 deaths nationally.
    [Show full text]
  • Weekly Bayesian Modelling Strategy to Predict Deaths by Covid-19: Amodelandcasestudyforthe State of Santa Catarina,Brazil
    WEEKLY BAYESIAN MODELLING STRATEGY TO PREDICT DEATHS BY COVID-19: A MODEL AND CASE STUDY FOR THE STATE OF SANTA CATARINA,BRAZIL Pedro Henrique da Costa Avelar1,2, Luis C. Lamb2, Sophia Tsoka3, and Jonathan Cardoso-Silva 1,3∗ 1Data Science Brigade, Porto Alegre, Brazil 2Institute of Informatics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil 3Department of Informatics, King’s College London, London, United Kingdom ABSTRACT Background: The novel coronavirus pandemic has affected Brazil’s Santa Catarina State (SC) severely. At the time of writing (24 March 2021), over 764,000 cases and over 9,800 deaths by COVID-19 have been confirmed, hospitals were fully occupied with local news reporting at least 397 people in the waiting list for an ICU bed. Despite initial state-wide measures at the outbreak of the pandemic, the state government passed most responsibilities down to cities local government, leaving them to plan whether and when to apply Non-Pharmaceutical Interventions (NPIs). In an attempt to better inform local policy making, we applied an existing Bayesian algorithm to model the spread of the pandemic in the seven geographic macro-regions of the state. However, as we found that the model was too reactive to change in data trends, here we propose changes to extend the model and improve its forecasting capabilities. Methods: Our four proposed variations of the original method allow accessing data of daily reported infections and take into account under-reporting of cases more explicitly. Two of the proposed versions also attempt to model the delay in test reporting.
    [Show full text]
  • The Feasibility of Malaria Elimination on the Island of Hispaniola, with a Focus on Haiti
    The feasibility of malaria elimination on the island of Hispaniola, with a focus on Haiti An assessment conducted January–June 2013 Photo © 2012 Natalie Briggs/Global Health Outreach, Courtesy of Photoshare In St. Marc, Haiti, two boys play with playdough while their parents are at the dentist. The cover photograph is used for illustrative purposes only; it does not imply any particular health status, attitudes, behaviors, or actions on the part of any person who appears in the photograph. 1 Contents Abbreviations ................................................................................................................................................ 6 Executive Summary ....................................................................................................................................... 8 Objectives ................................................................................................................................................. 8 History ....................................................................................................................................................... 8 Current response ...................................................................................................................................... 8 Technical assessment ................................................................................................................................ 8 Operational assessment...........................................................................................................................
    [Show full text]
  • The Simulations Driving the World's Response to COVID-19
    Special report AFP/GETTY Staff at a car-manufacturing plant in Wuhan, China, observe social-distancing measures during their lunch break. had a day off since mid-January.” Research does not get much more policy-relevant than this. When updated data in the Imperial team’s model1 indicated that the United Kingdom’s health service would soon be overwhelmed with severe cases of COVID-19, MODELLING and might face more than 500,000 deaths if the government took no action, Prime Minister Boris Johnson almost immediately announced stringent new restrictions on people’s move- ments. The same model suggested that, with no action, the United States might face 2.2 million THE PANDEMIC deaths; it was shared with the White House and new guidance on social distancing quickly The simulations driving the world’s followed (see ‘Simulation shock’). response to COVID-19. By David Adam Governments across the world are relying on mathematical projections to help guide deci- sions in this pandemic. Computer simulations account for only a fraction of the data analyses hen Neil Ferguson visited than 36 hours later, he announced on Twitter that modelling teams have performed in the cri- the heart of British govern- that he had a fever and a cough. A positive test sis, Ferguson notes, but they are an increasingly ment in London’s Downing followed. The disease-tracking scientist had important part of policymaking. But, as he and Street, he was much closer become a data point in his own project. other modellers warn, much information about to the COVID-19 pandemic Ferguson is one of the highest-profile faces in how SARS-CoV-2 spreads is still unknown and than he realized.
    [Show full text]
  • The Laotian Hmong -- Their History, Culture and American Journey
    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2010 A New Life in Montana: The Laotian Hmong -- their History, Culture and American Journey David A. Keightley The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Keightley, David A., "A New Life in Montana: The Laotian Hmong -- their History, Culture and American Journey" (2010). Graduate Student Theses, Dissertations, & Professional Papers. 27. https://scholarworks.umt.edu/etd/27 This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. A NEW LIFE IN MONTANA: THE LAOTIAN HMONG – THEIR HISTORY, CULTURE AND AMERICAN JOURNEY By DAVID ANDREW KEIGHTLEY Master of Arts, Columbia International University, Columbia, SC, 2000 Bachelor of Arts, Montana State University, Bozeman, MT, 1991 Thesis Presented in partial fulfillment of the requirements for the degree of Master of Arts in History The University of Montana Missoula, MT May 2010 Approved by: Perry Brown, Associate Provost for Graduate Education Graduate School Michael Mayer, Chair History Department Harry Fritz History Department Steven Levine Mansfield Center Keightley, David, M.A., May 2010 History A New Life in Montana: The Laotian Hmong – Their History, Culture and American Journey Chairperson: Michael Mayer Following the end of the Vietnam War, hundreds of thousands of Vietnamese, Laotian and Cambodian refugees fled their homelands for America, where they started their lives over again.
    [Show full text]
  • Instant Lives
    Instant Lives by Howard Moss illustrated by Edward Gorey Ever wondered what happens between the lines of biography? If the lights and lives remained on after you closed the book? Perfect for those who love literature too much to hold it too closely to actual facts, Instant Lives’s imagined encounters between literary figures and their real or imagined family mem- bers, friends, and bitter enemies is guaranteed to delight. These fractured and fabricated lives are recounted in the clipping pace of Howard Moss’s witty prose and rendered by Edward Gorey, in his iconic, spindly black-and-white Victorian style. In Moss’s satirical voice and Gorey’s twenty-five deadpan illustrations, we see Jane Austen wielding artful passive aggres- sion and Sense & Sensibility galleys, the Alcott girls sculpting Format: Hardcover fudge, the rise of Emily Dickinson’s ruthless witch hazel business, ISBN: 978-1-56792-651-4 and (among other delights) the tiniest nun in Spain. Descend Size: 4 ¼ x 7 ¾ inches into literary chaos with Instant Lives—just add water (and a Pages: 104 little vinegar), and suspend disbelief. Price: $19.95 Publication: October 2019 Rights: World Howard Moss (1922–1987) was the poetry editor of The New Yorker for almost forty years, a role that he used to promote the work of then-little-known poets like Anne Sexton, Richard Wilbur, and Sylvia Plath. Hugely influential on American poetry as we know it today, Moss was also a poet himself, as well as a distinguished literary critic and a professor at Vassar. Edward Gorey (1925–2000) began his career as a child prod- igy, drawing at the age of two, reading by the age of three.
    [Show full text]